Table 1 Clinical characteristics of 45 children with OAB
From: Efficacy and safety of solifenacin combined with biofeedback in children with overactive bladder
Group A n = 15 | Group B n = 15 | Group C n = 15 | |
|---|---|---|---|
Age (years) | 7.1 ± 1.4 | 7.9 ± 1.1 | 7.6 ± 0.9 |
Male/female | 9 / 6 | 8 / 7 | 7 / 8 |
Duration of disease (months) | 4.2 | 3.9 | 4.1 |
Symptoms | |||
Frequent micturition (voiding frequency > 8 times in day time and/or > 2 times at night) | 15 (100.0%) | 15 (100.0%) | 15 (100.0%) |
Urgency | 15 (100.0%) | 15 (100.0%) | 15 (100.0%) |
Urge urinary incontinence | 8 (53.3%) | 7 (46.7%) | 8 (53.3%) |
Enuresis | 5 (33.3%) | 6 (40.0%) | 5 (33.3%) |
Constipation | 0 | 1 (6.7%) | 0 |
2-day frequency volume chart | |||
Maximum voided volume < 65% MCC | 15 (100.0%) | 15 (100.0%) | 15 (100.0%) |
Urodynamic study | |||
Increased Qmax | 12 (80.0%) | 11 (73.3%) | 12 (80.0%) |
Increased bladder sensation | 15 (100.0%) | 15 (100.0%) | 15 (100.0%) |
Decreased bladder compliance | 8 (53.3%) | 9 (60.0%) | 8 (53.3%) |
Detrusor instability | 6 (40.0%) | 7 (46.7%) | 7 (46.7%) |